Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant

McGill University

$245,496.00

Therapeutic potential of small-molecules targeting the toxins of Clostridium difficile

FY 2014-15

Summary
Clostridium difficile is a superbug that can causes serious diarrhoea in hospitalized patients, potentially resulting in death. The number and severity of infections has grown in the last 15 years because of the emergence of more virulent strains. Current antibiotic treatments for Clostridium difficile are inadequate, and new strategies are needed. Toxins produced by the bacteria are the primary cause of disease. We propose here a new method to inactivate these bacterial toxins in the intestine, before they provoke injury. This research has the potential to transform the treatment of this alarming infection.
Program
Operating Grant
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
321784
Name
Castagner Bastien
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Pharmaceutical Sciences
Projecttitle
Therapeutic potential of small-molecules targeting the toxins of Clostridium difficile
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$245,496
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Bacterial Toxins; Clostridium Difficile; Drug Discovery; Infectious Diseases; Medicinal Chemistry; Virulence Factors
Abstract
Clostridium difficile is a superbug that can causes serious diarrhoea in hospitalized patients, potentially resulting in death. The number and severity of infections has grown in the last 15 years because of the emergence of more virulent strains. Current antibiotic treatments for Clostridium difficile are inadequate, and new strategies are needed. Toxins produced by the bacteria are the primary cause of disease. We propose here a new method to inactivate these bacterial toxins in the intestine, before they provoke injury. This research has the potential to transform the treatment of this alarming infection.
Competitiondate
201503
Approvedterm2
4 yrs 0 mth
Pinamesdelim
Castagner, Bastien
Approvedterm
4 ans 0 mois
Cihrcontribution2
~ $245,496~ $0~
McGill University - $245,496 Grant (2014-15) | Canada Spends